When Rx-360 was first set-up, an interim board was appointed. To help with the principle that Rx-360 was global and not too US-centric, it was agreed that the chair and co-chair should come from different parts of the world. My role as Head of Supplier Quality Shared Service in GSK is a global role with me being based close to London. In my role, I am aware of the increasing difficulties we have to obtain access to suppliers and also the fact that there are few globally recognised standards for auditing pharmaceutical suppliers.

One of the most important aspects of the work of Rx-360 is to adopt and agree on global audit standards. We are working with other organisations such as PQG/IPEC to adopt existing standards.

One thing which has impressed me in working with the working groups and the Board has been the energy and commitment which people have shown to move all the working groups along so quickly. I am particularly looking forward to reviewing the first Rx-360 audit performed under the pilot scheme. This is expected to be available sometime after May.